10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $553,000 | -83.7% | 12,216 | -72.7% | 0.08% | -30.8% |
Q1 2022 | $3,403,000 | +192.6% | 44,740 | +472.9% | 0.12% | +103.4% |
Q4 2021 | $1,163,000 | -8.6% | 7,809 | +11.1% | 0.06% | -24.4% |
Q1 2021 | $1,273,000 | +16.8% | 7,029 | -19.6% | 0.08% | -38.6% |
Q3 2020 | $1,090,000 | – | 8,739 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |